Premium
Vascular α‐adrenergic responsiveness is reduced in cirrhosis
Author(s) -
Bierbrier Gordon S,
Adams Paul C,
Feldman Ross D
Publication year - 1994
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1994.192
Subject(s) - adrenergic , cirrhosis , medicine , cardiology , receptor
Cirrhosis of the liver is associated with altered cardiovascular regulation. Patients with cirrhosis often have decreased total peripheral vascular resistance despite increased sympathetic activity. To determine whether this reduction in effective sympathetic activity may be caused by an alteration in vascular adrenergic responsiveness, we studied nine patients with biopsy‐proven cirrhosis and 12 age‐matched control subjects. To assess human vascular adrenergic responsiveness, we used dorsal hand vein linear variable differential transformer techniques. Sensitivity for phenylephrine‐mediated vasoconstriction was significantly reduced in patients with cirrhosis (median effective dose [ED 50 ] for phenylephrine: cirrhosis, 1514 ng/min; control subjects, 282 ng/min; p = 0.026). In contrast, the effect of isoproterenol did not differ (cirrhosis: 89% ± 15% of maximal nitroglycerin effect; control subjects 79% ± 6%; ED 50 for isoproterenol: cirrhosis, 38 ng/min; control subjects, 20 ng/min). These studies indicate that vascular α‐adrenergic responsiveness in patients with cirrhosis is decreased, whereas β‐adrenergic responsiveness remains intact. A selective decrease in vascular α‐adrenergic responsiveness may contribute to the decreased peripheral vascular resistance in cirrhosis. Clinical Pharmacology and Therapeutics (1994) 56, 668–671; doi: 10.1038/clpt.1994.192